ArticleJournal of experimental & clinical cancer research : CR2019

TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.

Chuan-Yuan Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.